Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients With Lymphoproliferative Disorders on BTKi
Hemasphere
.
2023 May 4;7(5):e880.
doi: 10.1097/HS9.0000000000000880.
eCollection 2023 May.
Authors
Giulia Zamprogna
1
,
Anna Maria Frustaci
1
,
Giovanna Travi
2
,
Chiara Borella
3
,
Gianluigi Reda
4
,
Marina Motta
5
,
Marina Deodato
1
,
Elisa Bossi
3
,
Veronica Mattiello
4
,
Maria Beatrice Ferrari
1
,
Giulia Cotilli
1
,
Carlo Gambacorti-Passerini
3
6
,
Roberto Cairoli
1
,
Massimo Puoti
2
,
Alessandra Tedeschi
1
Affiliations
1
Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
2
Infectious Diseases Unit, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
3
Department of Hematology, Ospedale San Gerardo, Monza, Italy.
4
U.O.C. Ematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy.
5
SC Ematologia, ASST Spedali Civili Brescia, Brescia, Italy.
6
University of Milano-Bicocca, Monza, Italy.
PMID:
37153871
PMCID:
PMC10162789
DOI:
10.1097/HS9.0000000000000880
No abstract available